Stock Screener App

Frei -

Installieren

5.61

12.20% 0.61

Sage Therapeutics Inc (SAGE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SAGE? Forum Prognose

Finanzdaten der Sage Therapeutics Inc-Aktie (SAGE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	89.87% 7.902	77.97	2.716	2.474	3.294
Operating Expenses	4.61% 125.58	120.05	214.56	172.93	158.76
Benefits Costs and Expenses	5.16% 116.39	110.68	-	-	150.12
Costs And Expenses	5.16% 116.39	110.68	214.56	172.93	158.76
Operating Income/Loss	179.69% -117.67	-42.07	-211.85	-170.46	-155.47
Income/Loss From Continuing Operations Before Tax	231.69% -108.48	-32.71	2.716	-160.32	-146.83
Income/Loss From Continuing Operations After Tax	231.69% -108.48	-32.71	-201.63	-160.32	-146.83
Net Income/Loss	231.69% -108.48	-32.71	-201.63	-160.32	-146.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	119.72K% 60.14	0.0502	59.91	59.77	59.67
Diluted Average Shares	119.72K% 60.14	0.0502	59.91	59.77	59.67
Basic Earnings Per Share	233.33% -1.80	-0.54	-3.37	-2.68	-2.46
Diluted Earnings Per Share	233.33% -1.80	-0.54	-3.37	-2.68	-2.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters